QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=5E97C3C3AE9D673E6E3B4EB1B8D8154D;jsessionid=96EBF8EB968E3F5FA98845B414E70EE9;jsessionid=A4DA20E41614B20E2BCA3321E11E1A72;jsessionid=9A7A98FA41CF1C579F94F0F21863D660 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=5E97C3C3AE9D673E6E3B4EB1B8D8154D;jsessionid=96EBF8EB968E3F5FA98845B414E70EE9;jsessionid=A4DA20E41614B20E2BCA3321E11E1A72;jsessionid=9A7A98FA41CF1C579F94F0F21863D660